Seminars in Respiratory and Critical Care Medicine

Article	Citations
Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension	75
Improving Medication Adherence in Asthma	73
Pneumonia After Solid Organ Transplantation	54
Sleep, Circadian Rhythms, and Lung Cancer	53
State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens	47
Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis	45
Mechanical Ventilation for COVID-19 Patients	38
	36
Diffuse Alveolar Hemorrhage (DAH)	33
Nonmalignant Pleural Effusions	25
Severe Infections Due to Respiratory Viruses	25
	23
Impact of Marijuana Use on Lung Health	22
Advances in the Understanding and Management of Chronic Obstructive Pulmonary Disease	18
Prevention of Aspiration: Oral Care, Antibiotics, Others	17
Factors Influencing Glucocorticoid Treatment Response: Mechanism-Based Strategies to Overcome Glucocorticoid Resistance and Restore GRα Function	17
Indwelling Pleural Catheter: Management of Complications	16
The Oral–Lung Microbiome Axis in Connective Tissue Disease-Related Interstitial Lung Disease	16
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection	16
Imaging in the Intensive Care Unit	16
Lung Transplant for Chronic Obstructive Pulmonary Disease	16
Chronic Obstructive Pulmonary Disease and Work: The Continuing Narrative	16
	16
Management of Dyspnea in Patients with Neuromuscular Disorders	15
Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis	14

Deployment-Related Respiratory Disease: Where Are We?	13
COVID-19-Related Pleural Diseases	13
Antibiotic Strategies for Severe Community-Acquired Pneumonia	13
Diagnostic Approach to Interstitial Lung Diseases Associated with Connective Tissue Diseases	12
	12
Nocturnal Hypoxemia in Respiratory Medicine: Pathophysiology, Measurement, and Association with Outcomes	12
Chronic Pulmonary Aspergillosis: Clinical Presentation and Management	12
Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease Overlap Syndrome	12
Tissue Perfusion and Diffusion and Cellular Respiration: Transport and Utilization of Oxygen	11
Update on Sepsis Epidemiology in the Era of COVID-19	11
Definition and Epidemiology of Sepsis	11
Management of Pulmonary Hypertension Associated with Chronic Lung Disease	11
Pulmonary Physiology and Medicine of Diving	11
Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia	11
How to Survive Sepsis: Patient Testimonial	10
Survivorship Challenges and Supportive Care in Lung Cancer	10
Lung Cancer in Special Populations	10
Work-Related Sleep Disorders: Causes and Impacts	10
Understanding the Updates in the Asthma Guidelines	10
Bronchoscopic Lung Volume Reduction: A Review	10
Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease	10
Blood Gas Transport: Implications for O2 and CO2 Exchange in Lungs and Tissues	9
Beyond the Lungs—Emerging Challenges in Adult Cystic Fibrosis Care	9
Management of Acutely Decompensated Pulmonary Hypertension	9
Updates in Lung Cancer Screening: A Decade of Evidence	9
Community-Acquired Pneumonia: Postpandemic, Not Post-COVID-19	9
Emerging Concepts in Fibroblast Biology and Progressive Pulmonary Fibrosis	9
Interstitial Lung Disease Associated with Systemic Sclerosis	8
Clinical Features of COVID-19 and Differentiation from Other Causes of CAP	8
Malignant Central Airway Obstruction: What's New?	8
Pertussis Vaccination: The Challenges Ahead	8
Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients	8
Peeling Back the Layers of the Bleomycin Model of Lung Fibrosis: Lessons Learned, Factors to Consider, and Future Directions	8
Corticosteroid Treatment in Septic Shock	8
Comorbid Insomnia and Sleep Apnea: From Research to Clinical Practice	8
Aspergillus and the Lung	7
Pathological Diagnosis of Pulmonary Aspergillosis	7
Severe Community-Acquired Pneumonia	7
“Long Haulers”	7
Life-Threatening Infections: Pulmonary and Systemic Infections	7
Defining Clinical and Microbiological Nonresponse in Ventilator-Associated Pneumonia	7
Arterial Blood Gases and Acid–Base Regulation	7
Glucocorticoid Treatment in Community-Acquired Pneumonia	7
Intra-abdominal Infections	7
	7
Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis	7
Sleep and Circadian-Related Outcomes after Critical Illness	7
Control of Breathing	6
Interventional Pulmonology and the Esophagus: Tracheostomy and Percutaneous Endoscopic Gastrostomy Placement	6
Severe Community-Acquired Pneumonia in Immunocompromised Patients	6

Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management	6
Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias	6
Pulmonary Hypertension Associated with Left Heart Disease	6
HIV and COVID-19 Disease	6
Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for Therapy	6
Use of Antiviral Agents and other Therapies for COVID-19	6
Viral Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia	6
Early Diagnosis of Sepsis: The Role of Biomarkers and Rapid Microbiological Tests	6
Aspiration Pneumonia: Preface	6
Precision Medicine to Guide Obstructive Sleep Apnea Treatment Beyond the Continuous Positive Airway Pressure	6
Global Trends in Occupational Lung Disease	5
Imaging in Asthma Management	5
Gas Exchange in the Lung	5
Mediastinal Staging with Endobronchial Ultrasound in Early-Stage Non—Small Cell Lung Cancer: Is It Necessary?	5
Life After COVID-19: Alterations Related to Sleep and Circadian Rhythms	5
Approach to Pulmonary Nodules in Connective Tissue Disease	5
Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease	5
The Spectrum of Pulmonary Aspergillosis	5
Vaccination against Respiratory Infections in the Immunosenescent Older Adult Population: Challenges and Opportunities	5
Advances in Disease-Modifying Therapeutics for Chronic Neuromuscular Disorders	5
Safety, Efficacy, and Effectiveness of Maternal Vaccination against Respiratory Infections in Young Infants	5
Intrapleural Anticancer Therapy for Malignant Pleural Diseases: Facts or Fiction?	5
The Role of Viral Infections in the Development and Progression of COPD	5
Aspiration after Critical Illness: Role of Endotracheal Tube, Tracheostomy, and Swallowing Disorders	4
HAP and VAP after Guidelines	4
Chronic Thromboembolic Pulmonary Disease and Chronic Thromboembolic Pulmonary Hypertension	4
COVID-19 in Immunocompromised Patients: A Systematic Review	4
Clinical Epidemiology of Pediatric Coronavirus Disease 2019 and its Postacute Sequelae	4
Corrigendum: Severe Community-Acquired Pneumonia: Noninvasive Mechanical Ventilation, Intubation, and HFNT	4
COVID-19 Vaccines—All You Want to Know	4
Bronchoscopic Lung Volume Reduction for Emphysema: Review and Update	4
Importance of and Approach to Taking a History of Exposures to Occupational Respiratory Hazards	4
Risk of Multidrug-Resistant Pathogens in Severe Community-Acquired Pneumonia	4
Nebulized Antibiotics for Healthcare- and Ventilator-Associated Pneumonia	4
Bacteriology of Aspiration Pneumonia: The Lung Microbiome and the Changing Microbial Etiology	4
Malignancies Presenting with Alveolar Infiltrates: Diagnostic Pitfalls, Radiologic Clues, and Clinical Patterns	4
Phenotyping, Precision Medicine, and Asthma	4
	4
Pleural Diseases in Connective Tissue Diseases	4
Modeling Mechanical Ventilation In Silico—Potential and Pitfalls	4
Overview of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Its Treatment	4
Management of Severe Influenza	4
Dysregulation of Host–Pathogen Interactions in Sepsis: Host-Related Factors	4
Severe Community-Acquired Pneumonia: Noninvasive Mechanical Ventilation, Intubation, and HFNT	4
Emerging Concepts in Pathogenesis, Multiomics Applications, and Clinical Research in Lymphangioleiomyomatosis	4
Malignant Pleural Effusions in the Era of Immunotherapy and Antiangiogenic Therapy	4
The Evaluation of the Oncologic Patient for Drug-Induced Pneumonitis	4
Pulmonary Vascular Disease in Chronic Obstructive Pulmonary Disease	4
Navigating COPD in Aging Populations: Insights Into Pathophysiology and Comprehensive Care	4
The Glucocorticoid System: A Multifaceted Regulator of Mitochondrial Function, Endothelial Homeostasis, and Intestinal Barrier Integrity	4
Expert Review on Spontaneous Pneumothorax: Advances, Controversies, and New Directions	4
Imaging of Lung Disease Associated with Connective Tissue Disease	3
Systemic Lupus Erythematosus-related Lung Disease	3
Nutrition in Asthma	3
High-Resolution Computed Tomography of Cystic Lung Disease	3
Lysosomal Storage Disorders	3
Aspiration Pneumonia	3
Early Experience on Universal Prophylaxis in Infants against Respiratory Syncytial Virus: Facts and Expectations	3
Management of Pulmonary Arterial Hypertension	3
	3
Environmental Interventions for Asthma	3
Glucocorticoid Treatment for Hospital-Acquired and Ventilator-Associated Pneumonia	3
Cystic Fibrosis	3
	3
	3
Update on Drug-Induced Pneumonitis in Lung Cancer	3
Nonmalignant Central Airway Obstruction: Options for Challenging Cases	3
Antimicrobial Strategies for Cystic Fibrosis	3
Evaluation of Neuromuscular Disease in Adults Presenting with Dyspnea	3
Swallowing and Aspiration: How to Evaluate and Treat Swallowing Disorders Associated with Aspiration Pneumonia in Older Persons	3
Ventilation Mechanics	3
	3
Transmission and Risk Factors of COVID-19 among Health Care Workers	3
Techniques for Oxygenation and Ventilation in Coronavirus Disease 2019	3
Medical Emergencies in Pulmonary Hypertension	2
Pulmonary Amyloidosis	2
Glucocorticoid Treatment in Severe COPD Exacerbations: Biological Rationale, Clinical Effects, and Practical Advice	2
Middle East Respiratory Syndrome Coronavirus	2
Imaging of Lung Cancer Staging	2
General Approach to Immunocompromised Patients with Pneumonia: Insights from the Latest Consensus Documents	2

Glucocorticoid Therapy in COVID-19	2
Advances in Multimodality Management of Localized Non-Small Cell Lung Cancer	2
Sepsis from Science to Social Perspective	2
Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators	2
Blood Gas Transport: Carriage of Oxygen and Carbon Dioxide in Blood	2
Exercise and Airway Clearance Techniques in Cystic Fibrosis	2
Genetics and social determinants of health as drivers of epidemiologic variation in sarcoidosis	2
Aspiration after Anesthesia: Chemical versus Bacterial, Differential Diagnosis, Management, and Prevention	2
New Insights in the Pathophysiology of Hospital- and Ventilator-Acquired Pneumonia: A Complex Interplay between Dysbiosis and Critical-Illness–Related Immunosuppression	2
Five Questions to Help Prompt End-of-Life Planning in Neuromuscular Disease	2
Viral Respiratory Infections: From Bench to Bedside	2
Review of Pulmonary Physiology	2
Sepsis and Septic Shock: Evolving Evidence, Evolving Paradigms	2
Heterogeneity of Lung Phagocytes and Clearance of Apoptotic Cells in Lung Injury and Repair	2
Epigenetic Mechanisms in Sepsis-Associated Acute Kidney Injury	2
New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia	2